S
SomnoMed
SomnoMed Limited develops, produces, commercializes, and sells devices for the oral treatment of sleep related disorders
About SomnoMed
SomnoMed is a leading provider of Continuous Open Airway Therapy (COAT) solutions for the treatment of Obstructive Sleep Apnea (OSA). The company specializes in creating innovative and comfortable oral appliances that help patients maintain an open airway during sleep. SomnoMed serves a diverse clientele, including patients, dental providers, and medical providers, by offering high-quality, FDA-cleared products that are customized for individual needs. Operating in the medical and dental markets, SomnoMed's business model revolves around the development, manufacturing, and distribution of its proprietary devices. The company generates revenue through the direct sale of these devices to healthcare providers and patients, as well as through partnerships with medical and dental practices. SomnoMed's commitment to quality, innovation, and customer satisfaction is evident in its ISO 13485 certified manufacturing processes and the long-term durability of its products, which come with a three-year warranty. The company's mission is to improve the health and well-being of its customers by providing effective and comfortable sleep solutions.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Founded
- 2004
- Headquarters
- Sydney, Australia
- Listing
- IPO 2004
- Sector
- Health Tech & Medtech
- Power Law
- Colt$25–100M revenue
Knowledge graph
More headlines
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Market sentiment
An AI-synthesised read of the highest-engagement posts about SomnoMed on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See SomnoMed on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.